DURHAM, N.C. — Two antibiotic testing platforms developed by BioMerieux recently received market leadership awards from consulting firm Frost & Sullivan.

The VITEK 2 andVITEK 2 Compact platforms are used for infectious disease antibiotic susceptibility testing.

BioMerieux tests are now used in more than 60 percent of U.S.-based hospitals and most automated microbiological labs. The company received the Frost & Sullivan awards based on market share, revenue growth rate, profitability and innovative technology.

BioMerieux: www.biomerieux.com